Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Goodwill & Intangibles: 2017-2025

Historic Goodwill & Intangibles for Autolus Therapeutics (AUTL) over the last 4 years, with Sep 2025 value amounting to $20.3 million.

  • Autolus Therapeutics' Goodwill & Intangibles was N/A to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Autolus Therapeutics' Goodwill & Intangibles is $20.3 million, which was up 56.83% from $12.9 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Goodwill & Intangibles ranged from a high of $20.3 million in Q3 2025 and a low of $8,000 during Q3 2022.
  • Moreover, its 2-year median value for Goodwill & Intangibles was $12.7 million (2025), whereas its average is $14.5 million.
  • Data for Autolus Therapeutics' Goodwill & Intangibles shows a maximum YoY crashed of 90.80% (in 2022) over the last 5 years.
  • Autolus Therapeutics' Goodwill & Intangibles (Quarterly) stood at $65,000 in 2021, then slumped by 90.80% to $8,000 in 2022, then reached $12.4 million in 2024, then reached $20.3 million in 2025.
  • Its Goodwill & Intangibles stands at $20.3 million for Q3 2025, versus $12.9 million for Q2 2025 and $12.5 million for Q1 2025.